戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 his effect differs depending on CD4-positive T-lymphocyte count.
2 elation of these changes with overall CD4(+) T lymphocyte counts.
3 outgrowth patterns and inversely with CD4(+) T lymphocyte counts.
4 d undetectable viral loads and intact CD4(+) T-lymphocyte counts.
5 sma HIV-1 viral load and increases in CD4(+) T-lymphocyte counts.
6 d in 267 (15%) of 1748 patients (median CD4+ T-lymphocyte count, 242 per cubic millimeter; interquart
7 igher weight, serum albumin levels, and CD4+ T-lymphocyte counts (492 +/- 828 cells/mm3 versus 57 +/-
8 o the immunologic parameters of blood CD4(+) T lymphocyte count and breadth of the HIV-1-specific CTL
9  hazards models revealed that both the total T lymphocyte count and CD8 T lymphocyte count provided i
10                        The mean+/-SEM CD4(+) T lymphocyte count and virus load for all patients were
11                                          CD4 T lymphocyte counts and all virologic parameters examine
12 herapy regimens can increase circulating CD4 T lymphocyte counts and decrease the risk of opportunist
13 icantly associated with higher activated CD8 T lymphocyte counts and higher viral load levels.
14 s group of patients with relatively high CD4 T lymphocyte counts and low measures of virus load at ba
15  characteristic pattern of low CD4+ and CD8+ T-lymphocyte counts and low CD5+ B-lymphocyte counts.
16                                 Serum CD4(+) T-lymphocyte counts and SIV copy numbers did not differ
17  of these measures and current or nadir CD4+ T-lymphocyte counts, and each measure was compared betwe
18 tive (PPD) tuberculin and mumps antigen, CD4 T-lymphocyte counts, and frequency of tuberculosis.
19 donor with a low viral burden, stable CD4(+) T-lymphocyte counts, and little evidence of CD8(+) T-cel
20 tive increase in the peripheral blood CD4(+) T-lymphocyte count as compared with that of nonsmokers.
21 abundant thymic tissue had higher naive CD4+ T lymphocyte counts at weeks 2-24 after therapy than ind
22 he heralding manifestation of AIDS, high CD4 T-lymphocyte count at disease onset, lesion enhancement
23                 Immunity was assessed by CD4 T-lymphocyte counts at AIDS onset.
24                The animal had declining CD4+ T-lymphocyte counts at the time of the LN biopsy.
25 remia coincided with recovery of normal CD8+ T lymphocyte counts between days 48 and 76.
26 ns of IP-10/CXCL10, whereas CD4(+)/HLA-DR(+) T lymphocyte counts correlated positively with serum con
27                     Activated CD4(+)/CD25(+) T-lymphocyte counts correlated negatively with serum con
28                                        A CD4 T-lymphocyte count determines eligibility for antiretrov
29                                     Low CD4+ T-lymphocyte count, disease stage, performance status, s
30                                       CD4(+) T lymphocyte counts, eosinophil counts, and plasma HIV-1
31 ycin sulfate, and among patients with a CD4+ T-lymphocyte count greater than 0.200 x 10(9)/L (200/mic
32 h an HIV-1 RNA load <50 copies/mL and CD4(+) T lymphocyte count &gt;400 cells/mm(3) were randomized to u
33 lex [MAC] infection) in persons whose CD4(+) T lymphocyte counts had increased by >/=100 cells/microL
34  1); (2) HIV-infected individuals whose CD4+ T-lymphocyte counts had always been more than 200/microL
35 dary OI prophylaxis among persons whose CD4+ T lymphocyte counts have increased in response to antire
36  therapy and level of immunodeficiency (CD4+ T lymphocyte count, human immunodeficiency virus [HIV] R
37 es, as demonstrated by an increase in CD4(+) T-lymphocyte counts in recent clinical trials.
38 ociated with reduced increases in the CD4(+) T lymphocyte count, irrespective of plasma HIV RNA level
39 ART) is recommended when the absolute CD4(+) T lymphocyte count is <200 cells/mm(3), and it should be
40 e Hospital, London, who had at least one CD4 T lymphocyte count of < 5 cells/mm3 (n = 166) were prosp
41 ntiretroviral-naive patients with a mean CD4 T lymphocyte count of 659 cells/microliter at baseline a
42 s to 55 HIV-1-infected individuals with CD4+ T lymphocyte counts of 50-500 cells/microL.
43 NA values of 50 copies/mL or fewer and a CD4 T-lymphocyte count of 100 cells/mL or greater or patient
44 related pulmonary complications, with a CD4+ T-lymphocyte count of 331.6 +/- 62.1 (mean +/- SEM).
45 ents with untreated HIV infection with a CD4 T-lymphocyte count of 500 cells/mL or greater.
46 -infected individuals with a history of CD4+ T-lymphocyte counts of less than 50/microL, but with cur
47  changes in their total T lymphocyte and CD8 T lymphocyte counts over time.
48 ; P < .001); and larger CRAE with lower CD4+ T lymphocyte count (P = .04).
49 pillomavirus infection (p=0.0013), lower CD4 T lymphocyte count (p = 0.0395), and history of frequent
50  (P = 0.018) and increases in peripheral CD4 T lymphocyte counts (P < 0.01).
51 with baseline CD4+, CD4+CD28+, and CD8+CD28+ T lymphocyte counts (P<.05) and inversely correlated wit
52  low hemoglobin (p = 0.11), and CD4-positive T-lymphocyte count (p = 0.04).
53 se who developed tuberculosis had lower CD4+ T-lymphocyte counts (P = 0.02) and were more likely to b
54              Among the 134 patients with CD4 T-lymphocyte counts performed within 3 months of Cryptos
55 at both the total T lymphocyte count and CD8 T lymphocyte count provided important prognostic informa
56 retions were negatively correlated with CD4+ T lymphocyte count (r=-0.44, P<.01 and r=-0.40, P<.01, r
57 s correlated significantly with current CD4+ T-lymphocyte count (r = - 0.344, P = 0.022).
58  during the peak of viremia, the milk CD4(+) T lymphocyte counts remained unchanged, despite active v
59 ee subgroups based on current and nadir CD4+ T-lymphocyte counts (severely immunosuppressed, immune r
60 are more likely to present with lower CD4(+) T-lymphocyte counts than MSM who do not attend church.
61          Patients in groups 1 and 2 had CD4+ T-lymphocyte counts that were similar to those in patien
62                                         CD4+ T lymphocyte counts, time to first HIV-1 disease progres
63 e-art HIV diagnostic technologies for CD4(+) T lymphocyte count, viral load measurement, and drug res
64    The mean (SD) age was 35 (6.9) years, CD4 T-lymphocyte count was 236 (139) and log10 plasma HIV RN
65 ral load of <400 copies/mL), and median CD4+ T-lymphocyte count was 459 cells/mm(3) (interquartile ra
66 oad of <400 copies/mL, and the median CD4(+) T-lymphocyte count was 471 cells/microL.
67                          In this group, CD4+ T-lymphocyte count was low, despite a significantly lowe
68 viral load and sustained decreases in CD4(+) T lymphocyte count were observed, especially in subjects
69     Current and nadir (lowest previous) CD4+ T-lymphocyte counts were identified for each subject.
70                                          CD4 T-lymphocyte counts were substantially higher in the lon
71 greater virologic suppression and higher CD4 T-lymphocyte counts when managed by a multidisciplinary

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。